Conference call cleared up some major points for RAP.
Tech works however was poorly tested. This is good but scary. Good - potential for retesting and improvements from results. Scary - with a company like RAP why was it poorly tested in the first place? This also brings up the question of WTF was management doing.
I am not one to give advice or try and predict outcomes of stocks, however for all those who lost major money like myself (bought in at rap at 40c) please do your own research and ensure that you are content with what management is doing and how much the product can actually grow.
FDA approval is looking a life time away at this moment.
Retesting is funded however, keep in mind how long we waited for those results.
Day traders have come in at 0.05-0.10c and cleaned up so again keep in mind that they have made their money and major swings may happen at any time.
And again for those people like myself still hurting from that hit on Wednesday... life goes on and its not the end of the world. The sun will rise again. So sit tight for now.
Try not to get personally attached to any stock. If you can weigh up your wins and loses and learn to take a hit when it happens, you will go further than dwelling on what is to come.
Again, GLTA.
DMD
Conference Call Summary, page-228
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #